Skip to main content

Chugai Pharmaceuticals Value Stock - Dividend - Research Selection

Chugai Pharmaceuticals Co., Ltd.

ISIN: JP3519400000, WKN: 857216

Market price date: 08.01.2021
Market price: 5.535,00 JPY

Chugai Pharmaceuticals Co., Ltd. Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 03-02-2020
Cash flow
Net operating cash flow 206.641.000.000
Capital Expenditures -
Free cash flow 153.631.997.952
Balance sheet
Total Equity 853.985.000.000
Liabilities & Shareholders equity 1.058.920.000.000
Income statement
Net income 157.560.000.000
Eps (diluted) 95,810
Diluted shares outstanding 1.644.500.000
Net sales/revenue 686.184.000.000

Fundamental ratios calculated on: 08-01-2021

Key figures 08-01-2021
Cash flow
P/C 0,00
P/FC 0,00
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization87.756.767.232,00 USD
IndicesNIKKEI 225
Raw Data SourceIFRS in Millionen JPY
Stock Split2020-06-29,3.000000/1.000000

Description of the company

CHUGAI PHARMACEUTICAL CO., LTD. is a pharmaceutical company based in Japan. The Domestic segment is engaged in the sale of pharmaceutical products manufactured by the company through its nationwide stores. This segment also covers the research, development, transport and storage of pharmaceutical products, as well as providing literature research for pharmaceutical information. The Overseas segment is active in the distribution of its pharmaceutical products in overseas markets such as Germany, Great Britain, France, Taiwan, China Mainland, Korea and the United States. This segment is also involved in providing pharmaceutical academic information as well as research, development and registration of pharmaceutical products. As of December 31, 2013, the Company had 20 subsidiaries.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,